The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus
Bioscience Reports · 2025
DOI: 10.1042/bsr20250001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, 2025. Verfasst von Jin-Ju Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Biotechnology, Korea University, Anam-dong, Sungbuk-gu, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Antifungal Agents, Fluoroquinolones, Echinocandins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea University.
Abstract (Originalsprache)
The antifungal drugs of the echinocandin family show high efficacy against Aspergillus fumigatus. However, their paradoxical effect, which restores fungal growth at high drug concentrations, and the emergence of resistant strains necessitate improvements. We identified 13 fluoroquinolone compounds from a chemical library containing 10,000 compounds that potentiate the antifungal activity of caspofungin. Among them, NE-E07 significantly enhanced the efficacy of echinocandins against A. fumigatus, including resistant strains, without potentiating other antifungal families like voriconazole or amphotericin B. Specifically, NE-E07 demonstrated a unique ability to potentiate caspofungin’s activity against the echinocandin-resistant strain USHM-M0051 isolated from patients. Our experiments revealed that NE-E07, in combination with caspofungin, affected ergosterol biosynthesis in a manner consistent with azole drugs. Docking tests suggest that NE-E07 has a high binding affinity with CYP51, which affects ergosterol biosynthesis similarly to azole drugs. Interestingly, known fluoroquinolones like ciprofloxacin, nalidixic acid, and norfloxacin did not show this potentiating effect, suggesting that NE-E07’s unique structure is critical for its activity. Moreover, NE-E07 did not enhance echinocandin activity against Candida albicans or Cryptococcus neoformans, highlighting its specific action against A. fumigatus. In vivo studies demonstrated that co-treatment with NE-E07 and caspofungin increased the survival rate of mice infected with A. fumigatus. This significant improvement in survival underscores the potential clinical relevance of NE-E07 as a co-administered drug with echinocandins for treating fungal infections, particularly those resistant to echinocandins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Biotechnology, Korea University, Anam-dong, Sungbuk-gu, Seoul, Republic of Korea.
- EsgelBio Co, Anam-dong, Sungbuk-gu, Seoul, Republic of Korea.
- Department of Plant Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
ORCID-Profile: Cheol-Won Yun
Förderung
- Korea University
Zitieren
APA
Choi, J. J., Kang, S., Lee, Y., Lee, D. H., Jang, Y., Goo, J. I., Choi, Y., Lee, D., & Yun, C. W. (2025). The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus. Bioscience Reports. https://doi.org/10.1042/bsr20250001
Vancouver
Choi JJ, Kang S, Lee Y, Lee DH, Jang Y, Goo JI, et al. The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus. Bioscience Reports. 2025. doi:10.1042/bsr20250001
BibTeX
@article{Choi2025,
author = {Choi, Jin-Ju and Kang, Suzie and Lee, Yoonseo and Lee, Dong-Hyun and Jang, Yuju and Goo, Ja-Il and Choi, Yongseok and Lee, Dongho and Yun, Cheol-Won},
title = {The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus},
journal = {Bioscience Reports},
year = {2025},
doi = {10.1042/bsr20250001}
}
EUVIMED